메뉴 건너뛰기




Volumn 107, Issue 1, 1999, Pages 69-79

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

Author keywords

Acute myeloid leukaemia; Cytogenetics; Prognostic index; Response; Risk directed therapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; HYDROCORTISONE; METHOTREXATE;

EID: 0008381951     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01684.x     Document Type: Article
Times cited : (379)

References (21)
  • 2
    • 0001593390 scopus 로고    scopus 로고
    • Allo and auto BMT reduce relapse risk in AML, in CR1 but do not significantly improve overall survival: Results of the MRC AML 10 trial
    • A1184
    • Burnett, A.K., Goldstone, A.H., Stevens, R., Hann, I.M., Gray, R., Rees, J. & Wheatley, K. (1996) Allo and auto BMT reduce relapse risk in AML, in CR1 but do not significantly improve overall survival: results of the MRC AML 10 trial. British Journal of Haematology, 93, (Suppl. 2), 313 (A1184).
    • (1996) British Journal of Haematology , vol.93 , Issue.SUPPL. 2 , pp. 313
    • Burnett, A.K.1    Goldstone, A.H.2    Stevens, R.3    Hann, I.M.4    Gray, R.5    Rees, J.6    Wheatley, K.7
  • 3
    • 0032492441 scopus 로고    scopus 로고
    • Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial
    • Burnett, A.K., Goldstone, A.H., Stevens, R.F., Hunn, I.M., Rees, J.K.H., Gray, R.G. & Wheatley, K. (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet, 351, 700-708.
    • (1998) Lancet , vol.351 , pp. 700-708
    • Burnett, A.K.1    Goldstone, A.H.2    Stevens, R.F.3    Hunn, I.M.4    Rees, J.K.H.5    Gray, R.G.6    Wheatley, K.7
  • 5
    • 0031052186 scopus 로고    scopus 로고
    • Acute promyelocytic leukemia: Biology and treatment
    • Fenaux, P., Chomienne, C. & Degos, L. (1997) Acute promyelocytic leukemia: biology and treatment. Seminars in Oncology, 24, 92-102.
    • (1997) Seminars in Oncology , vol.24 , pp. 92-102
    • Fenaux, P.1    Chomienne, C.2    Degos, L.3
  • 7
    • 4243452748 scopus 로고    scopus 로고
    • Identification of good risk elderly patients with acute myeloid leukaemia (AML) who benefit from intensive therapy and extremely poor risk ones who do not: Prognostic factor analysis of the MRC AML 11 trial
    • A1154
    • Goldstone, A.H., Burnett, A.K., Wheatley, K. & Gray, R.G. (1996) Identification of good risk elderly patients with acute myeloid leukaemia (AML) who benefit from intensive therapy and extremely poor risk ones who do not: prognostic factor analysis of the MRC AML 11 trial. Blood, 88, (Suppl. 1), 291a (A1154).
    • (1996) Blood , vol.88 , Issue.SUPPL. 1
    • Goldstone, A.H.1    Burnett, A.K.2    Wheatley, K.3    Gray, R.G.4
  • 8
    • 0025765054 scopus 로고
    • How to avoid bias when comparing bone marrow transplantation with chemotherapy
    • Gray, R. & Wheatley, K. (1991) How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplantation, 7, (Suppl. 3), 9-12.
    • (1991) Bone Marrow Transplantation , vol.7 , Issue.SUPPL. 3 , pp. 9-12
    • Gray, R.1    Wheatley, K.2
  • 9
    • 9444225115 scopus 로고    scopus 로고
    • Establishing the presence of the t(15:17) in suspected acute promyelocytic leukaemia: Cytogenic, molecular and PML immunofluorescence assessment of patients entered into the MRC ATRA trial
    • Grimwade, D., Howe, K., Langabeer, S., Davies, L., Oliver, F., Walker, H., Swirsky, D., Wheatley, K., Goldstone, A., Burnett, A. & Solomon, E. (1996) Establishing the presence of the t(15:17) in suspected acute promyelocytic leukaemia: cytogenic, molecular and PML immunofluorescence assessment of patients entered into the MRC ATRA trial. British Journal of Haematology, 94, 557-573.
    • (1996) British Journal of Haematology , vol.94 , pp. 557-573
    • Grimwade, D.1    Howe, K.2    Langabeer, S.3    Davies, L.4    Oliver, F.5    Walker, H.6    Swirsky, D.7    Wheatley, K.8    Goldstone, A.9    Burnett, A.10    Solomon, E.11
  • 11
    • 0030895252 scopus 로고    scopus 로고
    • Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the medical research council's 10th AML trial (MRC AML 10)
    • Hann, I.M., Stevens, R.F., Goldstone, A.H., Rees, J.K.H., Wheatley, K., Gray, R.G. & Burnett, A.K. (1997) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML 10). Blood, 89, 2311-2318.
    • (1997) Blood , vol.89 , pp. 2311-2318
    • Hann, I.M.1    Stevens, R.F.2    Goldstone, A.H.3    Rees, J.K.H.4    Wheatley, K.5    Gray, R.G.6    Burnett, A.K.7
  • 12
    • 0028600064 scopus 로고
    • Expression of multi-drug resistance-associated protein (MRP) in acute leukemia
    • Hart, S.M., Ganeshaguru, K., Hoffbrand, A.V., Prentice, H.G. & Mehta, A.B. (1994) Expression of multi-drug resistance-associated protein (MRP) in acute leukemia. Leukemia, 8, 2163-2168.
    • (1994) Leukemia , vol.8 , pp. 2163-2168
    • Hart, S.M.1    Ganeshaguru, K.2    Hoffbrand, A.V.3    Prentice, H.G.4    Mehta, A.B.5
  • 13
    • 0028618803 scopus 로고
    • Flow cytometric analysis of cell surface and intracellular antigens in leukemia diagnosis
    • Knapp, W., Strobl, H. & Majidic, O. (1994) Flow cytometric analysis of cell surface and intracellular antigens in leukemia diagnosis. Cytometry, 18, 187-198.
    • (1994) Cytometry , vol.18 , pp. 187-198
    • Knapp, W.1    Strobl, H.2    Majidic, O.3
  • 14
    • 0027443004 scopus 로고
    • Age- and gender-related heterogeneity of cancer chromosome aberrations
    • Mertens, F., Johansson, B. & Mitelman, F. (1993) Age- and gender-related heterogeneity of cancer chromosome aberrations. Cancer Genetics and Cytogenetics, 70, 6-11.
    • (1993) Cancer Genetics and Cytogenetics , vol.70 , pp. 6-11
    • Mertens, F.1    Johansson, B.2    Mitelman, F.3
  • 17
    • 0009540170 scopus 로고    scopus 로고
    • The impact of allogeneic (Allo-BMT) and autologous (A-BMT) bone marrow transplant in first complete remission (CRJ) on quality of life (QL) of patients with acute myeloid leukaemia (AML) entered into the MRC AML 10 trial
    • Watson, M., Wheatley, K., Burnett, A.K., Goldstone, A.H., Rees, J.K. & Gray, R.G. (1996) The impact of allogeneic (Allo-BMT) and autologous (A-BMT) bone marrow transplant in first complete remission (CRJ) on quality of life (QL) of patients with acute myeloid leukaemia (AML) entered into the MRC AML 10 trial. British Journal of Haematology, 91, (Suppl. 2), 146.
    • (1996) British Journal of Haematology , vol.91 , Issue.SUPPL. 2 , pp. 146
    • Watson, M.1    Wheatley, K.2    Burnett, A.K.3    Goldstone, A.H.4    Rees, J.K.5    Gray, R.G.6
  • 18
    • 0001361131 scopus 로고
    • A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML 10 trial
    • A2381
    • Wheatley, K., Burnett, A., Goldstone, A., Hann, I., Stevens, R., Rees, J. & Gray, R. (1995) A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom Medical Research Council (MRC) AML 10 trial. Blood, 86, (Suppl. 1), 598a (A2381).
    • (1995) Blood , vol.86 , Issue.SUPPL. 1
    • Wheatley, K.1    Burnett, A.2    Goldstone, A.3    Hann, I.4    Stevens, R.5    Rees, J.6    Gray, R.7
  • 19
    • 0009519419 scopus 로고    scopus 로고
    • Factors relating to the achievement of complete remission (CR) in younger patients with acute myeloid leukaemia (AML) in the United Kingdom medical research council (MRC) AML 10 trial
    • A8431
    • Wheatley, K., Burnett, A.K., Goldstone, A.H., Hann, I.M., Stevens, R.F., Rees, J.K.H. & Gray, R.G. (1996) Factors relating to the achievement of complete remission (CR) in younger patients with acute myeloid leukaemia (AML) in the United Kingdom Medical Research Council (MRC) AML 10 trial. Blood, 88, (Suppl. 1), 214a (A8431).
    • (1996) Blood , vol.88 , Issue.SUPPL. 1
    • Wheatley, K.1    Burnett, A.K.2    Goldstone, A.H.3    Hann, I.M.4    Stevens, R.F.5    Rees, J.K.H.6    Gray, R.G.7
  • 20
    • 0028244591 scopus 로고
    • P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival
    • Wood, P., Burgess, R., MacGregor, A. & Yin, J.A. (1994) P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival. British Journal of Haematology, 87, 509-514.
    • (1994) British Journal of Haematology , vol.87 , pp. 509-514
    • Wood, P.1    Burgess, R.2    MacGregor, A.3    Yin, J.A.4
  • 21
    • 0030825611 scopus 로고    scopus 로고
    • Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: A cross-sectional study of the EORTC-GIMEMA AML 8A trial
    • Zittoun, R., Suciu, S., Solbu, G., Watson, M., Muus, P., Mandelli, P., Stryckmans, P., Peetermans, M., Thaler, J., Resegotti, L., Dardenne, M. & Willemze, R. (1997) Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplantation, 20, 307-315.
    • (1997) Bone Marrow Transplantation , vol.20 , pp. 307-315
    • Zittoun, R.1    Suciu, S.2    Solbu, G.3    Watson, M.4    Muus, P.5    Mandelli, P.6    Stryckmans, P.7    Peetermans, M.8    Thaler, J.9    Resegotti, L.10    Dardenne, M.11    Willemze, R.12


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.